Your browser doesn't support javascript.
loading
A Novel Aptamer LL4A Specifically Targets Vemurafenib-Resistant Melanoma through Binding to the CD63 Protein.
Li, Hui; Liu, Juan; Xiao, Xiaojuan; Sun, Shuming; Zhang, Hui; Zhang, Yibin; Zhou, Weihua; Zhang, Bin; Roy, Mridul; Liu, Hong; Ye, Mao; Wang, Zi; Liu-Smith, Feng; Liu, Jing.
Afiliação
  • Li H; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China.
  • Liu J; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China.
  • Xiao X; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China.
  • Sun S; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China.
  • Zhang H; Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Collaborative Innovation Center for Chemistry and Molecular Medicine, Hunan University, Changsha 410082, China.
  • Zhang Y; Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Collaborative Innovation Center for Chemistry and Molecular Medicine, Hunan University, Changsha 410082, China.
  • Zhou W; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China; Department of Obstetrics and Gynecology, People's Hospital of Xiangxi Tujia and Miao Autonomous Prefecture, Hunan, Jishou 410006, China.
  • Zhang B; Department of Histology and Embryology, Xiangya School of Medicine, Central South University, Changsha 410013, China.
  • Roy M; Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Collaborative Innovation Center for Chemistry and Molecular Medicine, Hunan University, Changsha 410082, China.
  • Liu H; The First Xiangya Hospital, Central South University, Changsha 410078, China.
  • Ye M; Molecular Science and Biomedicine Laboratory, State Key Laboratory for Chemo/Biosensing and Chemometrics, College of Biology, College of Chemistry and Chemical Engineering, Collaborative Innovation Center for Chemistry and Molecular Medicine, Hunan University, Changsha 410082, China.
  • Wang Z; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China; The First Xiangya Hospital, Central South University, Changsha 410078, China. Electronic address: zhongnanwangzi@126.com.
  • Liu-Smith F; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China; Department of Epidemiology, School of Medicine, University of California, Irvine, Irvine, CA 92697, USA. Electronic address: liufe@uci.edu.
  • Liu J; Molecular Biology Research Center, School of Life Sciences, Central South University, Changsha 410078, China. Electronic address: liujing2@sklmg.edu.cn.
Mol Ther Nucleic Acids ; 18: 727-738, 2019 Dec 06.
Article em En | MEDLINE | ID: mdl-31726389
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Mol Ther Nucleic Acids Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China